<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-life-11-00214">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fraser</surname>
    <given-names>G.A.</given-names>
   </name>
  </person-group>
  <article-title>The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)</article-title>
  <source>CNS Neurosci. Ther.</source>
  <year>2009</year>
  <volume>15</volume>
  <fpage>84</fpage>
  <lpage>88</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1755-5949.2008.00071.x</pub-id>
  <?supplied-pmid 19228182?>
  <pub-id pub-id-type="pmid">19228182</pub-id>
 </element-citation>
</ref>
